Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75550.42 1090.89 (1.47%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
1	Abbott India Ltd.	Q V PT	54,384 Mid Cap	25,731.15 (0.54%)	33.68	10.51	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Neuland Laboratories Ltd.	Q V+ PT	25,276 Small Cap	19,550.15 (-0.77%)	50.78	12.51	16.64	37.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Divis Laboratories Ltd.	Q V+ PT	2,57,903 Large Cap	9,966 (2.58%)	88.17	14.6	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,430.30 (0.36%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Astrazeneca Pharma India Ltd.	Q V PT	15,918 Small Cap	6,350.30 (-0.27%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,734.45 (-1.27%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Procter & Gamble Health Ltd.	Q V PT	9,436 Small Cap	5,725 (0.71%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,552 Small Cap	5,309.50 (0.56%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Alkem Laboratories Ltd.	Q V PT	61,277 Mid Cap	5,089.40 (-0.69%)	28.4	4.28	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,597.90 (-0.80%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Acutaas Chemicals Ltd.	Q V+ PT	32,770 Small Cap	4,000.20 (-0.06%)	74.62	17.64	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Pfizer Ltd.	Q V PT	16,867 Small Cap	3,630 (-1.55%)	22.94	3.83	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Kwality Pharmaceuticals Ltd.	Q V+ PT	3,604 Small Cap	3,511.15 (1.08%)	44.47	10.11	13.94	34.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	7,911 Small Cap	3,489.60 (1.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Ajanta Pharma Ltd.	Q V+ PT	43,891 Mid Cap	3,425.80 (-2.47%)	34.76	9.03	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Sanofi India Ltd.	Q V PT	7,380 Small Cap	3,310 (3.30%)	17.86	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Gland Pharma Ltd.	Q V PT	51,112 Mid Cap	3,069 (-0.92%)	45.28	4.81	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	42,073 Mid Cap	2,560.85 (3.11%)	39.39	16.69	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	NGL Fine-Chem Ltd.	Q V PT	1,576 Small Cap	2,557.20 (0.24%)	27.55	4.53	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	RPG Life Sciences Ltd.	Q V+ PT	4,255 Small Cap	2,525.50 (-1.82%)	38.89	6.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Mankind Pharma Ltd.	Q V PT	1,02,797 Mid Cap	2,510.55 (0.88%)	45.84	5.85	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Glenmark Pharmaceuticals Ltd.	Q V+ PT	65,137 Mid Cap	2,390.40 (3.57%)	36.23	5.94	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,380 (-0.50%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Caplin Point Laboratories Ltd.	Q V PT	17,672 Small Cap	2,342.70 (0.77%)	26.56	4.81	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Hester Biosciences Ltd.	Q V PT	1,956 Small Cap	2,282.30 (-0.76%)	14.37	4.3	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,187.30 (1.92%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,027.70 (0.93%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Ipca Laboratories Ltd.	Q V+ PT	48,907 Mid Cap	1,966 (1.99%)	39.32	5.86	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Wockhardt Ltd.	Q V+ PT	30,814 Small Cap	1,881 (-0.80%)	75.34	6.12	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Emcure Pharmaceuticals Ltd.	Q V PT	35,440 Small Cap	1,876.40 (0.44%)	35.04	6.78	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,188	-4.60%
Bliss GVS Pharma	623	-3.92%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Ajanta Pharma - Quaterly Results

The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90 millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	17250.70	12202.40	41.37	32137.40	24288.00	32.32	48459.20	43220.40	12.12
Other Income	526.20	750.30	-29.87	1234.40	1156.60	6.73	2044.00	1198.70	70.52
PBIDT	5697.10	3646.20	56.25	10372.30	7346.50	41.19	14023.90	13245.90	5.87
Interest	7.90	7.30	8.22	15.50	14.60	6.16	25.90	46.00	-43.70
PBDT	5689.20	3638.90	56.34	10356.80	7331.90	41.26	13998.00	13199.90	6.05
Depreciation	463.00	419.20	10.45	896.10	822.30	8.97	1687.70	1399.30	20.61
PBT	5226.20	3219.70	62.32	9460.70	6509.60	45.33	12310.30	11800.60	4.32
TAX	1427.30	724.40	97.03	2507.10	1464.60	71.18	2842.10	2631.70	7.99
Deferred Tax	-158.10	64.70	-344.36	-94.60	97.60	-196.93	76.00	51.40	47.86
PAT	3798.90	2495.30	52.24	6953.60	5045.00	37.83	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	33.03	29.88	10.52	32.27	30.25	6.70	28.94	30.65	-5.57

Oct, 2026

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

The total consolidated income of the company has increased by 32.07% at Rs 2,219.38 crore for Q2FY27

Oct, 2026

Laurus Labs reports over two-fold jump in Q2 consolidated net profit

The total consolidated income of the company has increased by 32.07% at Rs 2,219.38 crore for Q2FY27

Oct, 2026

Kovai Medical Center & Hospital informs about updates

Kovai Medical Center & Hospital has informed that it enclosed the details of Adjudication order received by the Company from the Joint Commissioner of Customs, Office of the Principal Commissioner of Customs (Air Cargo),Chennai.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sanofi India - Quaterly Results

The quarter ended September 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 4917.00 millions.The Profit for the quarter ended September 2026 of Rs. 1167.00 millions grew by 53.55% from Rs. 760.00 millions.Operating profit for the quarter ended September 2026 rose to 1667.00 millions as compared to 1391.00 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202512	202412	% Var
Sales	4917.00	4754.00	3.43	14017.00	14176.00	-1.12	18374.00	20132.00	-8.73
Other Income	55.00	49.00	12.24	161.00	169.00	-4.73	197.00	165.00	19.39
PBIDT	1667.00	1391.00	19.84	4354.00	4179.00	4.19	5110.00	5073.00	0.73
Interest	2.00	4.00	-50.00	8.00	11.00	-27.27	17.00	15.00	13.33
PBDT	1665.00	1114.00	49.46	4346.00	3895.00	11.58	4820.00	4681.00	2.97
Depreciation	88.00	91.00	-3.30	267.00	278.00	-3.96	373.00	367.00	1.63
PBT	1577.00	1023.00	54.15	4079.00	3617.00	12.77	4447.00	4314.00	3.08
TAX	410.00	263.00	55.89	1051.00	967.00	8.69	1180.00	1177.00	0.25
Deferred Tax	3.00	-49.00	-106.12	4.00	-52.00	-107.69	-49.00	-81.00	-39.51
PAT	1167.00	760.00	53.55	3028.00	2650.00	14.26	3267.00	3137.00	4.14
Equity	230.00	230.00	0.00	230.00	230.00	0.00	230.00	230.00	0.00
PBIDTM(%)	33.90	29.26	15.87	31.06	29.48	5.37	27.81	25.20	10.37

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Abbott India Ltd.	54,384 Crore
2	Neuland Laboratories Ltd.	25,276 Crore
3	Divis Laboratories Ltd.	2,57,903 Crore
4	Apollo Hospitals Enterprise Ltd.	1,20,779 Crore
5	Astrazeneca Pharma India Ltd.	15,918 Crore
6	Kovai Medical Center & Hospital Ltd.	6,356 Crore
7	Procter & Gamble Health Ltd.	9,436 Crore
8	Dr Agarwals Eye Hospital Ltd.	2,552 Crore
9	Alkem Laboratories Ltd.	61,277 Crore
10	Torrent Pharmaceuticals Ltd.	1,76,306 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,380	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,668	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,239	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,550	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,028	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,390	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,731	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Corona Remedies informs about newspaper publication

Ajanta Pharma - Quaterly Results

Laurus Labs hits 52-week high on reporting over two-fold jump in Q2 consolidated net profit

Laurus Labs reports over two-fold jump in Q2 consolidated net profit

Kovai Medical Center & Hospital informs about updates

Sanofi India - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?